Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients : a mono-institutional experience
LAKOSI, Ferenc; DE CUYPERE, Marjolein; NGUYEN, Viet Paulet al.
LAKOSI, Ferenc ; Centre Hospitalier Universitaire de Liège - CHU > Service médical de radiothérapie
DE CUYPERE, Marjolein ; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique
NGUYEN, Viet Paul ; Centre Hospitalier Universitaire de Liège - CHU > Service médical de radiothérapie
JANSEN, Nicolas ; Centre Hospitalier Universitaire de Liège - CHU > Service médical de radiothérapie
WARLIMONT, Bernard ; Centre Hospitalier Universitaire de Liège - CHU > Service médical de radiothérapie
GULYBAN, Akos ; Centre Hospitalier Universitaire de Liège - CHU > Service médical de radiothérapie
GENNIGENS, Christine ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
SEIDEL, Laurence ; Centre Hospitalier Universitaire de Liège - CHU > Service d'Informations médico économiques (SIME)
DELBECQUE, Katty ; Centre Hospitalier Universitaire de Liège - CHU > Anatomie pathologique
COUCKE, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Service médical de radiothérapie
HERMESSE, Johanne ; Centre Hospitalier Universitaire de Liège - CHU > Service médical de radiothérapie
KRIDELKA, Frédéric ; Centre Hospitalier Universitaire de Liège - CHU > Gynécologie-Obstétrique
Language :
English
Title :
Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients : a mono-institutional experience
Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC). Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: Individual patient data meta-analysis. Cochrane Database Syst Rev 2010; CD008285.
Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005; 74: 235-45.
Pötter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006; 78: 67-77.
Pötter R, Georg P, Dimopoulos JC, Grimm M, Berger D, Nesvacil N, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011; 100: 116-23.
Schmid MP, Fidarova E, Pötter R, Petric P, Bauer V, Woehs V, et al. Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervix cancer radiotherapy. Acta Oncol 2013; 52: 1384-90.
van de Schoot AJAJ, de Boer P, Buist MR, Stoker J, Bleeker MCG, Stalpers LJA, et al. Quantification of delineation errors of the gross tumor volume on magnetic resonance imaging in uterine cervical cancer using pathology data and deformation correction. Acta Oncol 2015; 54: 224-31.
Nomden CN, de Leeuw AAC, Moerland MA, Roesink JM, Tersteeg RJH, Jürgenliemk-Schulz IM. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2012; 82: 1424-30.
Fokdal L, Tanderup K, Hokland SB, Røhl L, Pedersen EM, Nielsen SK, et al. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component. Radiother Oncol 2013; 107: 63-8.
Palmqvist T, Dybdahl Wanderås A, Langeland Marthinsen AB, Sundset M, Langdal I, Danielsen S, et al. Dosimetric evaluation of manually and inversely optimized treatment planning for high dose rate brachytherapy of cervical cancer. Acta Oncol 2014; 53: 1012-8.
Hellebust TP, Kirisits C, Berger D, Pérez-Calatayud J, De Brabandere M, De Leeuw A, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: Considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol 2010; 96: 153-60.
Dimopoulos JCA, Petrow P, Tanderup K, Petric P, Berger D, Kirisits C, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol 2012; 103: 113-22.
Charra-Brunaud C, Harter V, Delannes M, Haie-Meder C, Quetin P, Kerr C, et al. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: Results of the French STIC prospective study. Radiother Oncol 2012; 103: 305-13.
Lindegaard JC, Fokdal LU, Nielsen SK, Juul-Christensen J, Tanderup K. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncol 2013; 52: 1510-9.
Nomden CN, de Leeuw AAC, Roesink JM, Tersteeg RJHA, Moerland MA, Witteveen PO, et al. Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: A single institution experience. Radiother Oncol 2013; 107: 69-74.
Rijkmans EC, Nout RA, Rutten IHHM, Ketelaars M, Neelis KJ, Laman MS, et al. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy. Gynecol Oncol 2014; 135: 231-8.
Gill BS, Kim H, Houser CJ, Kelley JL, Sukumvanich P, Edwards RP, et al. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: The University of Pittsburgh experience. Int J Radiat Oncol Biol Phys 2015; 91: 540-7.
Fokdal L, Tanderup K, Nielsen SK, Christensen HK, Røhl L, Pedersen EM, et al. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept. Radiother Oncol 2011; 100: 473-9.
Haie-Meder C, Chargari C, Rey A, Dumas I, Morice P, Magné N. DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery. Radiother Oncol 2009; 93: 316-21.
Tanderup K, Fokdal L, Sturdza AE, Mazeron R, Kirisits C, Lindegaard JC. Dose-response for local control in image guided cervix brachytherapy in the retro EMBRACE study. Radiother Oncol 2013; 106: S103-4.
Mazeron R, Castelnau-Marchand P, Dumas I, Del Campo ER, Kom LK, Martinetti F, et al. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy. Radiother Oncol 2015; 114: 257-63.
Dimopoulos JCA, Lang S, Kirisits C, Fidarova EF, Berger D, Georg P, et al. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2009; 75: 56-63.
Mohamed S, Kallehauge J, Fokdal L, Lindegaard JC, Tanderup K. Parametrial boosting in locally advanced cervical cancer: Combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy. Brachytherapy 2015; 14: 23-8.
Nomden CN, de Leeuw AAC, Roesink JM, Tersteeg RJH, Westerveld H, Jürgenliemk-Schulz IM. Intra-fraction uncertainties of MRI guided brachytherapy in patients with cervical cancer. Radiother Oncol 2014; 112: 217-20.
Mazeron R, Champoudry J, Gilmore J, Dumas I, Goulart J, Oberlander A-S, et al. Intrafractional organs movement in three-dimensional image-guided adaptive pulsed-dose-rate cervical cancer brachytherapy: Assessment and dosimetric impact. Brachytherapy 2015; 14: 260-6.
Berkey FJ. Managing the adverse effects of radiation therapy. Am Fam Physician 2010; 82: 381-8, 394. [cited 2015 May 15]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20704169.
Levitchi M, Charra-Brunaud C, Quetin P, Haie-Meder C, Kerr C, Castelain B, et al. Impact of dosimetric and clinical parameters on clinical side effects in cervix cancer patients treated with 3D pulse-dose-rate intracavitary brachytherapy. Radiother Oncol 2012; 103: 314-21.
Mazeron R, Dumas I, El Khouri C, Lévy A, Attar M, Haie-Meder C. [Intensity-modulated radiotherapy in cervical cancer: towards a new standard?]. Cancer Radiother 2014; 18: 154-60; quiz 162, 164.
Ahmad R, Bondar L, Voet P, Mens J.-W, Quint S, Dhawtal G, et al. A margin-of-the-day online adaptive intensity-modulated radiotherapy strategy for cervical cancer provides superior treatment accuracy compared to clinically recommended margins: A dosimetric evaluation. Acta Oncol 2013; 52: 1430-6.
